Eli Lilly reported $15.56bn in revenue, driven by its weight loss and diabetes drugs, intensifying pressure on rival Novo Nordisk.

Primary packaging is never an afterthought in the world of injectable drugs, where systems such as vials, syringes, and ...

Bayer disclosed that its Q2 earnings were inflated by transfer fees at its German football club Bayer Leverkusen.

The health secretary has halted the development of 22 mRNA vaccine projects by BARDA while stopping all future schemes.

Astria has made an exclusive licensing agreement with Kaken for the development and commercialisation rights of navenibart in Japan.

The US FDA has given accelerated approval to Jazz Pharma for Modeyso to treat adult and paediatric patients with diffuse midline glioma.